Published • loading... • Updated
Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval
Summary by studyfinds.com
1 Articles
1 Articles
Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval
After the FDA's 2021 approval, reported exposures more than doubled, and unintentional therapeutic errors remained the most common reason people contacted poison centers. The post Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval appeared first on StudyFinds.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
